iBio, Inc. Restricted Cash, Current
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2024-09-24
- 2024-03-31: Restricted Cash, Current $914.00K.
- 2023-12-31: Restricted Cash, Current $1.06M.
- 2023-09-30: Restricted Cash, Current $3.05M.
- 2023-06-30: Restricted Cash, Current $3.02M.
| Period end | Restricted Cash, Current |
|---|---|
| 2024-03-31 | $914.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $1.06M 10-Q · filed 2024-02-09 |
| 2023-09-30 | $3.05M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.02M 10-K/A · filed 2024-09-24 |